An mRNA platform makes macrophages produce fusion proteins combining phage tail proteins with antimicrobial peptides inside the cell, targeting intracellular Mycobacterium tuberculosis that evades conventional drugs.
Intracellular TB cleared by mRNAMacrophages reprogrammed to produce their own antimicrobial fusion proteins against hidden TB
What the researchers found
mRNA-mediated expression of fusion phage tail-AMP proteins inside macrophages enables targeted intracellular clearance of M. tuberculosis, overcoming the limitations of extracellular-focused anti-TB drugs.
Why it matters
TB kills 1.3 million people annually, and intracellular persistence drives treatment failure and recurrence. Turning macrophages into self-defending cells could revolutionize TB treatment.
How the study worked
In vitro mRNA expression platform development; fusion protein design combining phage tail protein and AMPs; intracellular Mtb killing assays in macrophages.
What this study cannot tell us
In vitro platform — in vivo delivery of mRNA to lung macrophages is a major challenge; fusion protein expression levels and duration need optimization; TB treatment requires prolonged therapy.
How to read the evidence
In vitro proof-of-concept study — innovative approach but significant development needed for clinical translation.
When this study was published
Published in 2026, applying mRNA therapeutic technology to the intracellular TB treatment challenge.
The bigger picture
This combines three technologies — mRNA therapy, phage biology, and antimicrobial peptides — into a cellular reprogramming approach that could transform how we treat any intracellular infection.
Questions still open
- Can mRNA lipid nanoparticles be delivered via inhalation to target lung macrophages harboring TB?
- Would this approach work against drug-resistant TB strains?
Common questions
Why is TB so hard to cure?
How does mRNA help fight TB?
Read the original research
mRNA mediated expression of novel fusion phage tail protein with antimicrobial peptides inside macrophages for targeted clearance of intracellular Mycobacterium tuberculosis.
Emerging microbes & infections, 15(1), 2627075
Citation
Chen, Ziwei; Fan, Xueting; Zhou, Liying; Zou, Lihui; Wan, Li; Li, Yayu; Li, Chang; Kuai, Lu; Cai, Jiahui; Zhang, Lili; Li, Yifei; Li, Hexin; Wan, Kanglin; Liu, Haican; Xu, Hongtao; Xiao, Fei. (2026). mRNA mediated expression of novel fusion phage tail protein with antimicrobial peptides inside macrophages for targeted clearance of intracellular Mycobacterium tuberculosis.. Emerging microbes & infections, 15(1), 2627075. https://doi.org/10.1080/22221751.2026.2627075